[ Price : $8.95]
Federal Register Proposed rule: FDA corrects an incorrect title in an 8/22 Federal Register proposed rule on revocation of general...[ Price : $8.95]
Federal Register Final order: FDA classifies dengue virus nucleic acid amplification test reagents into Class 2.[ Price : $8.95]
FDA approves a new indication for Astellas Pharma and Medivations Xtandi (enzalutamide) capsules to treat patients with metastatic...[ Price : $8.95]
A new Generic Pharmaceutical Association report shows that generic drugs saved the U.S. health system $239 billion in 2013, a 14% ...[ Price : $8.95]
AdverseEvents Inc. says its new drug safety report based on data provided by FDA in response to Freedom of Information Act request...[ Price : $8.95]
The Digital Health Coalition says industry practitioners need to work with FDA to find a better way to use Twitter and other commu...[ Price : $8.95]
Attorneys Jennifer Thomas and Anne Walsh say a federal judge has twice rejected FDA attempts to classify Prevors Diphoterine Skin ...[ Price : $8.95]
The Drug and Device Law blog says an FDA draft guidance on informed consent disclosure of alternative treatments puts drug and med...